ALXO · Alx Oncology Holdings Inc
United States · RS rating 29 · As of 2026-11-03
| Price | 1.29 USD |
|---|---|
| 1-day change | -5.8% |
| RS rating (overall / 1M / 3M / 12M) | 29 / 75 / 18 / 39 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 24 / 24 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -2.4% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +50.4% |
| Market cap (USD) | $214.0M |